Molecular Characterization of Clostridium difficile Isolates from Human Subjects and the Environment
Clostridium difficile is a spore-forming, gram-positive, anaerobic bacillus that can cause C. difficile infection (CDI). However, only a few studies on the prevalence and antibiotic resistance of C. difficile in healthy individuals in China have been reported. We employed a spore enrichment culture...
Gespeichert in:
Veröffentlicht in: | PloS one 2016-03, Vol.11 (3), p.e0151964 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 3 |
container_start_page | e0151964 |
container_title | PloS one |
container_volume | 11 |
creator | Tian, Tian-tian Zhao, Jian-hong Yang, Jing Qiang, Cui-xin Li, Zhi-rong Chen, Jing Xu, Kai-yue Ciu, Qing-qing Li, Ru-xin |
description | Clostridium difficile is a spore-forming, gram-positive, anaerobic bacillus that can cause C. difficile infection (CDI). However, only a few studies on the prevalence and antibiotic resistance of C. difficile in healthy individuals in China have been reported. We employed a spore enrichment culture to screen for C. difficile in the stool samples of 3699 healthy Chinese individuals who were divided into 4 groups: infants younger than 2 years of age and living at home with their parents; children aged 1 to 8 years of age and attending three different kindergarten schools; community-dwelling healthy adult aged 23-60 years old; and healthcare workers aged 28-80 years old. The C. difficile isolates were analyzed for the presence of toxin genes and typed by PCR ribotyping and multilocus sequence typing (MLST). The minimum inhibitory concentration of 8 antimicrobial agents was determined for all of the isolates using the agar dilution method. The intestinal carriage rate in the healthy children was 13.6% and ranged from 0% to 21% depending on age. The carriage rates in the 1654 community-dwelling healthy adults and 348 healthcare workers were 5.5% and 6.3%, respectively. Among the isolates, 226 were toxigenic (225 tcdA+/tcdB+ and 1 tcdA+/tcdB+ ctdA+/ctdB+). Twenty-four ribotypes were found, with the dominant type accounting for 29.7% of the isolates. The toxigenic isolates were typed into 27 MLST genotypes. All of the strains were susceptible to vancomycin, metronidazole, fidaxomicin, and rifaximin. High resistance to levofloxacin and ciprofloxacin at rates of 39.8% and 98.3%, respectively, were observed. ST37 isolates were more resistant to levofloxacin than the other STs. The PCR ribotypes and sequence types from the healthy populations were similar to those from the adult patients. |
doi_str_mv | 10.1371/journal.pone.0151964 |
format | Article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1775626226</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A453470436</galeid><doaj_id>oai_doaj_org_article_ef37b8d489cf4ef490eabc4dc69284c4</doaj_id><sourcerecordid>A453470436</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-afcce8a4dded2bd7eee54fb3204e48be01f44873774254e8784aa00fb4d655563</originalsourceid><addsrcrecordid>eNqNkl-L1DAUxYso7rr6DUQLguDDjPnXpvMiLMPqDqwsuOprSJObaYa2mU3SRf30pk53mYKC5CEh-d2Tk5uTZS8xWmLK8fudG3wv2-Xe9bBEuMCrkj3KTvGKkkVJEH18tD7JnoWwQ6igVVk-zU4IRxgTjE8z_dm1oIZW-nzdSC9VBG9_yWhdnzuTr1sXorfaDl2urTFW2RbyTXCtjBBy412XXw6d7PObod6BiiGXvc5jA_lFf2e96zvo4_PsiZFtgBfTfJZ9-3jxdX25uLr-tFmfXy1UuSJxIY1SUEmmNWhSaw4ABTM1JYgBq2pA2DBWcco5IwWDildMSoRMzXRZFEVJz7LXB919si2mBgWBOS9KUhIyEpsDoZ3cib23nfQ_hZNW_Nlwfiukj1a1IMBQXleaVStlGBi2QiBrxfTotWKKJa0P021D3YFW6aFetjPR-UlvG7F1d4JViKOCJIE3k4B3twOE-A_LE7WVyZXtjUtiqrNBiXNWUMYRoyO1_AuVhobOqhQRkz5uXvBuVpCYCD_iVg4hiM3Nl_9nr7_P2bdHbAOyjU2KyzAmKsxBdgCVdyF4MA-dw0iMCb_vhhgTLqaEp7JXx11_KLqPNP0NJCT4Hw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1775626226</pqid></control><display><type>article</type><title>Molecular Characterization of Clostridium difficile Isolates from Human Subjects and the Environment</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Tian, Tian-tian ; Zhao, Jian-hong ; Yang, Jing ; Qiang, Cui-xin ; Li, Zhi-rong ; Chen, Jing ; Xu, Kai-yue ; Ciu, Qing-qing ; Li, Ru-xin</creator><contributor>Deshpande, Abhishek</contributor><creatorcontrib>Tian, Tian-tian ; Zhao, Jian-hong ; Yang, Jing ; Qiang, Cui-xin ; Li, Zhi-rong ; Chen, Jing ; Xu, Kai-yue ; Ciu, Qing-qing ; Li, Ru-xin ; Deshpande, Abhishek</creatorcontrib><description>Clostridium difficile is a spore-forming, gram-positive, anaerobic bacillus that can cause C. difficile infection (CDI). However, only a few studies on the prevalence and antibiotic resistance of C. difficile in healthy individuals in China have been reported. We employed a spore enrichment culture to screen for C. difficile in the stool samples of 3699 healthy Chinese individuals who were divided into 4 groups: infants younger than 2 years of age and living at home with their parents; children aged 1 to 8 years of age and attending three different kindergarten schools; community-dwelling healthy adult aged 23-60 years old; and healthcare workers aged 28-80 years old. The C. difficile isolates were analyzed for the presence of toxin genes and typed by PCR ribotyping and multilocus sequence typing (MLST). The minimum inhibitory concentration of 8 antimicrobial agents was determined for all of the isolates using the agar dilution method. The intestinal carriage rate in the healthy children was 13.6% and ranged from 0% to 21% depending on age. The carriage rates in the 1654 community-dwelling healthy adults and 348 healthcare workers were 5.5% and 6.3%, respectively. Among the isolates, 226 were toxigenic (225 tcdA+/tcdB+ and 1 tcdA+/tcdB+ ctdA+/ctdB+). Twenty-four ribotypes were found, with the dominant type accounting for 29.7% of the isolates. The toxigenic isolates were typed into 27 MLST genotypes. All of the strains were susceptible to vancomycin, metronidazole, fidaxomicin, and rifaximin. High resistance to levofloxacin and ciprofloxacin at rates of 39.8% and 98.3%, respectively, were observed. ST37 isolates were more resistant to levofloxacin than the other STs. The PCR ribotypes and sequence types from the healthy populations were similar to those from the adult patients.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0151964</identifier><identifier>PMID: 27011211</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adult ; Adults ; Agar ; Age ; Aged ; Aged, 80 and over ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Anti-infective agents ; Antibiotic resistance ; Antibiotics ; Antimicrobial agents ; Bacteria ; Biology and Life Sciences ; Causes of ; Child ; Child, Preschool ; Children ; China - epidemiology ; Ciprofloxacin ; Clostridium difficile ; Clostridium difficile - drug effects ; Clostridium difficile - genetics ; Clostridium difficile - isolation & purification ; Communities ; Deoxyribonucleic acid ; Diarrhea ; Dilution ; DNA ; Drug Resistance, Bacterial ; Enterocolitis, Pseudomembranous - drug therapy ; Enterocolitis, Pseudomembranous - epidemiology ; Enterocolitis, Pseudomembranous - microbiology ; Female ; Genetic aspects ; Genotypes ; Glycerol ; Health aspects ; Health care ; High resistance ; Hospitals ; Humans ; Infant ; Infants ; Infections ; Intestine ; Intestines - microbiology ; Laboratories ; Levofloxacin ; Male ; Maternal & child health ; Medical personnel ; Medicine and Health Sciences ; Metronidazole ; Microbial Sensitivity Tests ; Middle Aged ; Minimum inhibitory concentration ; Multilocus Sequence Typing ; Parents ; People and Places ; Physiological aspects ; Prevalence ; Ribotyping ; Schools ; Studies ; Vancomycin ; Workers ; Young Adult</subject><ispartof>PloS one, 2016-03, Vol.11 (3), p.e0151964</ispartof><rights>COPYRIGHT 2016 Public Library of Science</rights><rights>2016 Tian et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2016 Tian et al 2016 Tian et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-afcce8a4dded2bd7eee54fb3204e48be01f44873774254e8784aa00fb4d655563</citedby><cites>FETCH-LOGICAL-c692t-afcce8a4dded2bd7eee54fb3204e48be01f44873774254e8784aa00fb4d655563</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807052/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807052/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,2928,23866,27924,27925,53791,53793,79600,79601</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27011211$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Deshpande, Abhishek</contributor><creatorcontrib>Tian, Tian-tian</creatorcontrib><creatorcontrib>Zhao, Jian-hong</creatorcontrib><creatorcontrib>Yang, Jing</creatorcontrib><creatorcontrib>Qiang, Cui-xin</creatorcontrib><creatorcontrib>Li, Zhi-rong</creatorcontrib><creatorcontrib>Chen, Jing</creatorcontrib><creatorcontrib>Xu, Kai-yue</creatorcontrib><creatorcontrib>Ciu, Qing-qing</creatorcontrib><creatorcontrib>Li, Ru-xin</creatorcontrib><title>Molecular Characterization of Clostridium difficile Isolates from Human Subjects and the Environment</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Clostridium difficile is a spore-forming, gram-positive, anaerobic bacillus that can cause C. difficile infection (CDI). However, only a few studies on the prevalence and antibiotic resistance of C. difficile in healthy individuals in China have been reported. We employed a spore enrichment culture to screen for C. difficile in the stool samples of 3699 healthy Chinese individuals who were divided into 4 groups: infants younger than 2 years of age and living at home with their parents; children aged 1 to 8 years of age and attending three different kindergarten schools; community-dwelling healthy adult aged 23-60 years old; and healthcare workers aged 28-80 years old. The C. difficile isolates were analyzed for the presence of toxin genes and typed by PCR ribotyping and multilocus sequence typing (MLST). The minimum inhibitory concentration of 8 antimicrobial agents was determined for all of the isolates using the agar dilution method. The intestinal carriage rate in the healthy children was 13.6% and ranged from 0% to 21% depending on age. The carriage rates in the 1654 community-dwelling healthy adults and 348 healthcare workers were 5.5% and 6.3%, respectively. Among the isolates, 226 were toxigenic (225 tcdA+/tcdB+ and 1 tcdA+/tcdB+ ctdA+/ctdB+). Twenty-four ribotypes were found, with the dominant type accounting for 29.7% of the isolates. The toxigenic isolates were typed into 27 MLST genotypes. All of the strains were susceptible to vancomycin, metronidazole, fidaxomicin, and rifaximin. High resistance to levofloxacin and ciprofloxacin at rates of 39.8% and 98.3%, respectively, were observed. ST37 isolates were more resistant to levofloxacin than the other STs. The PCR ribotypes and sequence types from the healthy populations were similar to those from the adult patients.</description><subject>Adult</subject><subject>Adults</subject><subject>Agar</subject><subject>Age</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Anti-infective agents</subject><subject>Antibiotic resistance</subject><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Bacteria</subject><subject>Biology and Life Sciences</subject><subject>Causes of</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>China - epidemiology</subject><subject>Ciprofloxacin</subject><subject>Clostridium difficile</subject><subject>Clostridium difficile - drug effects</subject><subject>Clostridium difficile - genetics</subject><subject>Clostridium difficile - isolation & purification</subject><subject>Communities</subject><subject>Deoxyribonucleic acid</subject><subject>Diarrhea</subject><subject>Dilution</subject><subject>DNA</subject><subject>Drug Resistance, Bacterial</subject><subject>Enterocolitis, Pseudomembranous - drug therapy</subject><subject>Enterocolitis, Pseudomembranous - epidemiology</subject><subject>Enterocolitis, Pseudomembranous - microbiology</subject><subject>Female</subject><subject>Genetic aspects</subject><subject>Genotypes</subject><subject>Glycerol</subject><subject>Health aspects</subject><subject>Health care</subject><subject>High resistance</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Infant</subject><subject>Infants</subject><subject>Infections</subject><subject>Intestine</subject><subject>Intestines - microbiology</subject><subject>Laboratories</subject><subject>Levofloxacin</subject><subject>Male</subject><subject>Maternal & child health</subject><subject>Medical personnel</subject><subject>Medicine and Health Sciences</subject><subject>Metronidazole</subject><subject>Microbial Sensitivity Tests</subject><subject>Middle Aged</subject><subject>Minimum inhibitory concentration</subject><subject>Multilocus Sequence Typing</subject><subject>Parents</subject><subject>People and Places</subject><subject>Physiological aspects</subject><subject>Prevalence</subject><subject>Ribotyping</subject><subject>Schools</subject><subject>Studies</subject><subject>Vancomycin</subject><subject>Workers</subject><subject>Young Adult</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNkl-L1DAUxYso7rr6DUQLguDDjPnXpvMiLMPqDqwsuOprSJObaYa2mU3SRf30pk53mYKC5CEh-d2Tk5uTZS8xWmLK8fudG3wv2-Xe9bBEuMCrkj3KTvGKkkVJEH18tD7JnoWwQ6igVVk-zU4IRxgTjE8z_dm1oIZW-nzdSC9VBG9_yWhdnzuTr1sXorfaDl2urTFW2RbyTXCtjBBy412XXw6d7PObod6BiiGXvc5jA_lFf2e96zvo4_PsiZFtgBfTfJZ9-3jxdX25uLr-tFmfXy1UuSJxIY1SUEmmNWhSaw4ABTM1JYgBq2pA2DBWcco5IwWDildMSoRMzXRZFEVJz7LXB919si2mBgWBOS9KUhIyEpsDoZ3cib23nfQ_hZNW_Nlwfiukj1a1IMBQXleaVStlGBi2QiBrxfTotWKKJa0P021D3YFW6aFetjPR-UlvG7F1d4JViKOCJIE3k4B3twOE-A_LE7WVyZXtjUtiqrNBiXNWUMYRoyO1_AuVhobOqhQRkz5uXvBuVpCYCD_iVg4hiM3Nl_9nr7_P2bdHbAOyjU2KyzAmKsxBdgCVdyF4MA-dw0iMCb_vhhgTLqaEp7JXx11_KLqPNP0NJCT4Hw</recordid><startdate>20160324</startdate><enddate>20160324</enddate><creator>Tian, Tian-tian</creator><creator>Zhao, Jian-hong</creator><creator>Yang, Jing</creator><creator>Qiang, Cui-xin</creator><creator>Li, Zhi-rong</creator><creator>Chen, Jing</creator><creator>Xu, Kai-yue</creator><creator>Ciu, Qing-qing</creator><creator>Li, Ru-xin</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20160324</creationdate><title>Molecular Characterization of Clostridium difficile Isolates from Human Subjects and the Environment</title><author>Tian, Tian-tian ; Zhao, Jian-hong ; Yang, Jing ; Qiang, Cui-xin ; Li, Zhi-rong ; Chen, Jing ; Xu, Kai-yue ; Ciu, Qing-qing ; Li, Ru-xin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-afcce8a4dded2bd7eee54fb3204e48be01f44873774254e8784aa00fb4d655563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Adults</topic><topic>Agar</topic><topic>Age</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Anti-infective agents</topic><topic>Antibiotic resistance</topic><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Bacteria</topic><topic>Biology and Life Sciences</topic><topic>Causes of</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>China - epidemiology</topic><topic>Ciprofloxacin</topic><topic>Clostridium difficile</topic><topic>Clostridium difficile - drug effects</topic><topic>Clostridium difficile - genetics</topic><topic>Clostridium difficile - isolation & purification</topic><topic>Communities</topic><topic>Deoxyribonucleic acid</topic><topic>Diarrhea</topic><topic>Dilution</topic><topic>DNA</topic><topic>Drug Resistance, Bacterial</topic><topic>Enterocolitis, Pseudomembranous - drug therapy</topic><topic>Enterocolitis, Pseudomembranous - epidemiology</topic><topic>Enterocolitis, Pseudomembranous - microbiology</topic><topic>Female</topic><topic>Genetic aspects</topic><topic>Genotypes</topic><topic>Glycerol</topic><topic>Health aspects</topic><topic>Health care</topic><topic>High resistance</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Infant</topic><topic>Infants</topic><topic>Infections</topic><topic>Intestine</topic><topic>Intestines - microbiology</topic><topic>Laboratories</topic><topic>Levofloxacin</topic><topic>Male</topic><topic>Maternal & child health</topic><topic>Medical personnel</topic><topic>Medicine and Health Sciences</topic><topic>Metronidazole</topic><topic>Microbial Sensitivity Tests</topic><topic>Middle Aged</topic><topic>Minimum inhibitory concentration</topic><topic>Multilocus Sequence Typing</topic><topic>Parents</topic><topic>People and Places</topic><topic>Physiological aspects</topic><topic>Prevalence</topic><topic>Ribotyping</topic><topic>Schools</topic><topic>Studies</topic><topic>Vancomycin</topic><topic>Workers</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tian, Tian-tian</creatorcontrib><creatorcontrib>Zhao, Jian-hong</creatorcontrib><creatorcontrib>Yang, Jing</creatorcontrib><creatorcontrib>Qiang, Cui-xin</creatorcontrib><creatorcontrib>Li, Zhi-rong</creatorcontrib><creatorcontrib>Chen, Jing</creatorcontrib><creatorcontrib>Xu, Kai-yue</creatorcontrib><creatorcontrib>Ciu, Qing-qing</creatorcontrib><creatorcontrib>Li, Ru-xin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tian, Tian-tian</au><au>Zhao, Jian-hong</au><au>Yang, Jing</au><au>Qiang, Cui-xin</au><au>Li, Zhi-rong</au><au>Chen, Jing</au><au>Xu, Kai-yue</au><au>Ciu, Qing-qing</au><au>Li, Ru-xin</au><au>Deshpande, Abhishek</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular Characterization of Clostridium difficile Isolates from Human Subjects and the Environment</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2016-03-24</date><risdate>2016</risdate><volume>11</volume><issue>3</issue><spage>e0151964</spage><pages>e0151964-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Clostridium difficile is a spore-forming, gram-positive, anaerobic bacillus that can cause C. difficile infection (CDI). However, only a few studies on the prevalence and antibiotic resistance of C. difficile in healthy individuals in China have been reported. We employed a spore enrichment culture to screen for C. difficile in the stool samples of 3699 healthy Chinese individuals who were divided into 4 groups: infants younger than 2 years of age and living at home with their parents; children aged 1 to 8 years of age and attending three different kindergarten schools; community-dwelling healthy adult aged 23-60 years old; and healthcare workers aged 28-80 years old. The C. difficile isolates were analyzed for the presence of toxin genes and typed by PCR ribotyping and multilocus sequence typing (MLST). The minimum inhibitory concentration of 8 antimicrobial agents was determined for all of the isolates using the agar dilution method. The intestinal carriage rate in the healthy children was 13.6% and ranged from 0% to 21% depending on age. The carriage rates in the 1654 community-dwelling healthy adults and 348 healthcare workers were 5.5% and 6.3%, respectively. Among the isolates, 226 were toxigenic (225 tcdA+/tcdB+ and 1 tcdA+/tcdB+ ctdA+/ctdB+). Twenty-four ribotypes were found, with the dominant type accounting for 29.7% of the isolates. The toxigenic isolates were typed into 27 MLST genotypes. All of the strains were susceptible to vancomycin, metronidazole, fidaxomicin, and rifaximin. High resistance to levofloxacin and ciprofloxacin at rates of 39.8% and 98.3%, respectively, were observed. ST37 isolates were more resistant to levofloxacin than the other STs. The PCR ribotypes and sequence types from the healthy populations were similar to those from the adult patients.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>27011211</pmid><doi>10.1371/journal.pone.0151964</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2016-03, Vol.11 (3), p.e0151964 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_1775626226 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Public Library of Science (PLoS) Journals Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry |
subjects | Adult Adults Agar Age Aged Aged, 80 and over Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Anti-infective agents Antibiotic resistance Antibiotics Antimicrobial agents Bacteria Biology and Life Sciences Causes of Child Child, Preschool Children China - epidemiology Ciprofloxacin Clostridium difficile Clostridium difficile - drug effects Clostridium difficile - genetics Clostridium difficile - isolation & purification Communities Deoxyribonucleic acid Diarrhea Dilution DNA Drug Resistance, Bacterial Enterocolitis, Pseudomembranous - drug therapy Enterocolitis, Pseudomembranous - epidemiology Enterocolitis, Pseudomembranous - microbiology Female Genetic aspects Genotypes Glycerol Health aspects Health care High resistance Hospitals Humans Infant Infants Infections Intestine Intestines - microbiology Laboratories Levofloxacin Male Maternal & child health Medical personnel Medicine and Health Sciences Metronidazole Microbial Sensitivity Tests Middle Aged Minimum inhibitory concentration Multilocus Sequence Typing Parents People and Places Physiological aspects Prevalence Ribotyping Schools Studies Vancomycin Workers Young Adult |
title | Molecular Characterization of Clostridium difficile Isolates from Human Subjects and the Environment |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T22%3A29%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20Characterization%20of%20Clostridium%20difficile%20Isolates%20from%20Human%20Subjects%20and%20the%20Environment&rft.jtitle=PloS%20one&rft.au=Tian,%20Tian-tian&rft.date=2016-03-24&rft.volume=11&rft.issue=3&rft.spage=e0151964&rft.pages=e0151964-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0151964&rft_dat=%3Cgale_plos_%3EA453470436%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1775626226&rft_id=info:pmid/27011211&rft_galeid=A453470436&rft_doaj_id=oai_doaj_org_article_ef37b8d489cf4ef490eabc4dc69284c4&rfr_iscdi=true |